Imaging of atherosclerosis: Carotid intima-media thickness

European Heart Journal

Volumn 31, Issue 14, 2010, Pages 1682-1689

  O'Leary, Daniel H ^a   Bots, Michiel L ^b  

^a TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

Atherosclerosis; Carotid intima media thickness; CIMT

Indexed keywords

CALCIUM;

ARTERIAL WALL THICKNESS; ARTERY INTIMA; ARTERY MEDIA; CARDIOVASCULAR RISK; CAROTID ARTERY; CAROTID ATHEROSCLEROSIS; DISEASE ASSOCIATION; DISEASE COURSE; INCIDENCE; INTRAVASCULAR ULTRASOUND; OUTCOME ASSESSMENT; PREDICTOR VARIABLE; PREVALENCE; PRIORITY JOURNAL; REPRODUCIBILITY; REVIEW; RISK ASSESSMENT; RISK REDUCTION;

ADULT; AGED; CAROTID ARTERIES; CAROTID ARTERY DISEASES; CLINICAL TRIALS AS TOPIC; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; RISK ASSESSMENT; STROKE; TUNICA INTIMA; TUNICA MEDIA; YOUNG ADULT;

EID: 77954812247     PISSN: 0195668X     EISSN: 15229645     Source Type: Journal    
DOI: 10.1093/eurheartj/ehq185     Document Type: Review

References (56)

1. Pignoli P, Tremoli E, Poli A, Oreste P, Paoletti R. Intimal plus medial thickness of the arterial wall: a direct measurement with ultrasound imaging. Circulation 1986; 74:1399-1406.
2. Polak JF, Person SD, Wei GS, Godreau A, Jacobs DR, Harrington A, Sidney S, O'Leary DH. Segment-specific associations of carotid intima-media thickness with cardiovascular risk factors: the Coronary Artery Risk Development in Young Adults (CARDIA) Study. Stroke 2010;41:41-47.
3. Touboul PJ, Hennerici MG, Meairs S, Adams H, Amarenco P, Bornstein N, Csiba L, Desvarieux M, Ebrahim S, Fatar M, Hernandez Hernandez R, Jaff M, Kownator S, Prati P, Rundek T, Sitzer M, Schminke U, Tardif JC, Taylor A, Vicaut E, Woo KS, Zannad F, Zureik M. Mannheim carotid intima-media thickness consensus (2004-2006). An update on behalf of the Advisory Board of the 3rd and 4th Watching the Risk Symposium, 13th and 15th European Stroke Conferences, 2004, Mannheim, Germany, 2007, 75-80 and Brussels, Belgium, 2006. Cerebro-vasc Dis23.
4. Kiechl S, Willeit J. The natural course of atherosclerosis. Part 1: incidence and progression. Aterioscler Thromb 1999;19:1484-1490.
5. Ku DN, Giddens DP, Zarins CK, Glagov S. Pusitile flow and atherosclerosis in the human carotid bifurcation. Positive correlation between plaque location and low oscillating shear stress. Arterioscler Thromb Vasc Biol 1985;5:293-302.
6. Malek AM, Alper SL, Izumo S. Hemodynamic shear stress and its role in atherosclerosis. JAMA 1999;282:2035-2042.
7. Kolodgie FD, Burke AP, Nakazawa G, Virmani R. Is pathologic intimal thickening the key to understanding early plaque progression in human atherosclerotic disease? Arterioscler Thromb Vasc Biol 2007;27:986-989.
8. Stein JH, Korcarz CE, Hurst RT, Lonn E, Kendall CB, Mohler ER, Najjar SS, Rembold CM, Post WS. Use of carotid ultrasound to identify subclinical disease and evaluate cardiovascular risk: a consensus statement from the American Society of Echocardiography Carotid Intima-Media Thickness Task Force endorsed by the Society of Vascular Medicine. J Am Soc Echocardiogr 2008;21: 93-111.
9. Bots ML, Evans GW, Riley WA, Grobbee DE. Carotid intima-media thickness measurements in interventional studies. Design options, progression rates, and sample size considerations: a point of view. Stroke 2003;34:2985-2994.
10. Tang R, Hennig M, Thomasson B, Scherz R, Ravinetto R, Catalini R, Rubba P, Zanchetti A, Bond MG, for the ELSA Investigators. Baseline reproducibility of B-mode ultrasonic measurement of carotid intima-media thickness: the European Lacidipine Study on Atherosclerosis (ELSA). J Hypertens 2000;18: 197-201.
11. Hulthe J, Wikstrand J, Emanuelsson H, Wiklund O, de Feyter PJ, Wendelhag I. Atherosclerosic changes in the carotid artery bulb as measured by B-mode ultrasound are associated with the extent of coronary atherosclerosis. Stroke 1997;28: 1189-1194.
12. Salonen JT, Salonen R. Ultrasonographically assessed carotid morphology and the risk of coronary heart disease. Arterioscler Thromb 1991;11:1245-1249.
13. Chambless LE, Heiss G, Folsom AR, Rosamond W, Szklo M, Sharrett AR, Clegg LX. Association of coronary heart disease incidence with carotid arterial wall thickness and major risk factors: the Atherosclerosis Risk in Communities (ARIC) Study, 1987-1993. Am J Epidemiol 1997;146:483-494.
14. Bots ML, Hoes AW, Koudstaal PJ, Hofman A, Grobbee DE. Common carotid artery intima-media thickness and risk of stroke and myocardial infarction: the Rotterdam Study. Circulation 1997;96:1432-1437.
15. O'Leary DH, Polak JF, Kronmal RA, Manolio TA, Burke GL, Wolfson SK Jr. Carotid-artery intima and media thickness as a risk factor for myocardial infarction and stroke in older adults. Cardiovascular Health Study. N Engl J Med 1999;340:14-22.
16. Lorenz MW, Markus HS, Bots ML, Rosvall M, Sitzer M. Prediction of clinical cardiovascular events with carotid intima-media thickness: a systematic review and meta-analysis. Circulation. 2007;115:459-467.
17. Anderson KM, Wilson PW, Odell PM, Kannel WB. An updated coronary risk profile. A statement for health professionals. Circulation 1991;83: 356-362.
18. Greenland P, Smith SC Jr, Grundy SM. Improving coronary heart disease risk assessment in asymptomatic people: role of traditional risk factors and noninva-sive cardiovascular tests. Circulation. 2001;104:1863-1867.
19. Wilson PWF, Smith SC, Blumenthal RS, Burke GL, Wong ND. 34th Bethesda Conference: Task force #4\How do we select patients for atherosclerosis imaging. JACC 2003;41:1898-1906.
20. Mancia G, de Backer G, Dominiczak A, Cifkova R, Heagerty AM, Kjeldsen SE, Laurent S, Narkiewicz K, Ruilopr L, Rynkiewicz A, Schmieder RE, Struijker Boudier HAJ, Zanchetti A. 2007 Guidelines for the management of arterial hypertension: the Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens 2007;25:1105-1187.
21. Cook NR. Use and misuse of the receiver operating characteristic curve in risk prediction. Circulation 2007;115:928-935.
22. Iglesias del Sol AI, Moons KGM, Hollander M, Hofman A, Koudstaal PJ, Grobbee DE, Breteler MMB, Witteman JCM, Bots ML. Is carotid intima-mendia thickness useful in cardiovascular disease risk assessment?: The Rotterdam Study. Stroke 2001;32:1532-1538.
23. Plantinga Y, Dogan S, Grobbee DE, Bots ML. Carotid intima-media thickness measurement in cardiovascular screening programmes. Eur J Cardiovasc Prev Rehabil 2009;16:639-644.
24. de Weerd M, Greving JP, de Jong AWF, Buskens E, Bots ML. Prevalence of asymptomatic carotid artery stenosis according to age and sex: systematic review and metaregression analysis. Stroke 2009;40;:1105-1113.
25. Furberg CD, Adams HP, Applegate WB, Byington RP, Espeland MA, Hartwell T, Hunninghake DB, Lefkowitz DS, Probstfield J, Riley WA, Young B, for the Asymptomatic Carotid Artery Progression Study (ACAPS) Research Group. Effect of lovastatin on early carotid atherosclerosis and cardiovascular events. Circulation 1994;90:1679-1687.
26. Revkin JH, Shear CL, Pouleur HG, Ryder SW, Orloff DG. Biomarkers in the prevention and treatment of atherosclerosis: need, validation, and future. Pharmacol Rev 2007;59:40-53.
27. Wang JG, Staessen JA, Li Y, Van Bortel LM, Nawrot T, Fagard R, Messerli FH, Safar M. Carotid intima-media thickness and antihypertensive treatment. Stroke 2006;37:1933-1940.
28. DCCT/EDIC Research Group: Nathan DM, Lachin J, Cleary P, Orchard T, Brillon DJ, Backlund J-Y, O'Leary DH, Genuth S. Invasive diabetes therapy and carotid intima-media thickness in Type 1 Diabetes Mellitus. N Engl J Med 2003; 348:2294-2303.
29. Yokoyama H, Katakami N, Yamasaki Y. Recent advances of interventions to inhibit progression of carotid intima-media thickness in patients with type 2 diabetes. Stroke 2006;37:2420-2427.
30. Crouse JR, Raichlen JS, Riley WA, Evans GW, Palmer MK, O'Leary DH, Grobee DE, Bots ML. Effect of rosuvastatin on progression of carotid intima-media thickness in low-risk individuals with subclinical atherosclerosis: the METEOR Trial. JAMA 2007;297:1344-1353.
31. Taylor AJ, Villines TC, Stanek EJ, Devine PJ, Griffen L, Miller M, Weissman NJ, Turco M. Extended-released niacin or ezetimibe and carotid intima-media thickness. N Engl J Med 2009;361:2113-2122.
32. Dogan S, Plantinga Y, Evans GW, Meijer R, Grobbee DE, Bots ML. Ultrasound protocols to measure carotid intima-media thickness: a post-hoc analysis of OPAL study. Curr Med Res Opin 2009;25:119-122.
33. Dogan S, Plantinga Y, Crouse JR, Evans GW, Raichlen JS, O'Leary DH, Palmer MK, Grobbee DE, Bots ML, on behalf of the METEOR Study Group. Ultrasound protocols to measure carotid intima-media thickness: a comparison of reproducibil-ity, rate of progression and treatment effect in asymptomatic subjects with mild to moderate subclinical atherosclerosis, the METEOR study. In: European Atherosclerosis Society Conference, 26 April 2008 Istanbul, Turkey.
34. Ainsworth CD, Blake CC, Tamayo A, Beletsky V, Fenster A, Spence JD. 3D ultrasound measurement of change in carotid plaque volume: a tool for rapid evaluation of new therapies. Stroke 2005;36:1904-1909.
35. Johnsen SH, Mathiesen EB, Joakimsen O, Stensland E, Wilsgaard T, Lochen M-L, Njolstad I, Arnesen E. Carotid atherosclerosis is a stronger predictor of myocar-dial infarction in women than in men: a 6-year follow-up study of 6226 persons: the Tromsv Study. Stroke 2007;38:2873-2880.
36. Hodis HN, Mack WJ, LaBree L, Selzer H, Liu C, Azen SP. The role of carotid arterial intima-media thickness in predicting clinical coronary events. Ann Intern Med 1998;128:262-269.
37. Espeland MA, O'Leary DH, Terry JG, Morgan T, Evans G, Mudra H. Carotid intimal-media thickness as a surrogate for cardiovascular disease events in trials of HMG-CoA reductase inhibitors. Curr Cont Trials Cardiovasc Med 2005;6:3.
38. Zanchetti A, Hennig M, Hollweck R, Bond G, Tang R, Cuspidi C, Parati G, Facchetti R, Mancia G. Baseline values but not treatment-induced changes in carotid intima-media thickness predict incident cardiovascular events in treated hypertensive patients: findings in the European Lacidipine Study on Atherosclerosis (ELSA). Circulation 2009;120:1084-1090.
39. Smilde TJ, Wissen SV, Wollersheim H, Trip M, Kastelein JJP, Stalenhoef AFH. Effect of aggressive versus conventional lipid lowering on atherosclerosis progression in familial hypercholesterolaemia (ASAP); a prospective, randomized double blind trial. Lancet 2001;357:577-581.
40. Nissen SE, Tuzcu EM, Schoenhagen P, Brown BG, Ganz P, Vogel RA, Crowe T, Howard G, Cooper CJ, Brodie B, Grines CL, DeMaria AN. Effect of intensive compared with moderate lipid-lowering therapy on progression of coronary atherosclerosis. JAMA 2004; 291:1071-1080.
41. Kastelein JJP, van Leuven SI, Burgess L, Evans GW, Kuivenhoven JA, Barter PJ, Revkin JH, Grobbee DE, Riley WA, Shear CL, Duggan WT, Bots ML, for the Radiance 1 Investigators. Effect of torcetrapib on carotid atherosclerosis in familial hypercholesterolemia. N Engl J Med 2007;356:1620-1630.
42. Nissen SE, Tardif J-C, Nicholls SJ, Revkin JH, Shear CL, Duggan WT, Ruzyllo W, Bachinsky WB, Lasala GP, Tuzcu EM. Effect of torcetrapib on the progression of coronary atherosclerosis. N Engl J Med 2007;356:1364-1366.
43. Nissen SE, Nicholls SJ, Sipahi I, Libby P, Raichlen JS, Ballantyne CM, Davignon J, Erbel R, Fruchart JC, Tardif JC, Schoenhagen P, Crowe T, Cain V, Wolski K, Goormastic M, Tuzcu EM. Effect of very high-intensity statin therapy on regression of coronary atherosclerosis: the ASTEROID trial. JAMA 2006;295: 1556-1565.
44. Mazzone T, Meyer PM, Feinstein SB, Davidson MH, Kondos GT, D'Agostino RB Sr, Perez A, Provost J-C, Haffner SM. Effect of pioglitazone compared with glime-piride on carotid intima-media thickness in type 2 diabetes: a randomized trial. JAMA 2006;296:2572-2581.
45. Nissen SE, Tuzcu EM, Brewer HB, Sipahi I, Nicholls SJ, Ganz P, Schoenhagen P, Waters DD, Pepine CJ, Crowe TD, Davidson MH, Deanfield JE, Wisniewski LM, Hanyok JJ, Kassalow LM, for the ACAT Intravascular Atherosclerosis Treatment Evaluation (ACTIVATE) Investigators. N Eng J Med 2006; 356:1304-1316.
46. Nissen SE, Nicholls SJ, Wolski K, Rodes-Cabau J, Cannon CP, Deanfield JE, Despres J-P, Kastelein JJP, Steinhubl SR, Kapadia S, Yasin M, Ruzyllo W, Gaudin C, Job B, Hu B, Bhatt DL, Lincoff AM, Tuzcu EM, for the STRADIVARIUS Investigators. Effect of rimonabant on progression of atherosclerosis in patients with abdominal obesity and coronary artery disease: the STRADIVARIUS randomized controlled trial. JAMA 2008;299:1547-1560.
47. Nissen SE, Nicholls SJ, Wolski K, Nesto R, Kupfer S, Perez A, Jure H, De Larochelliere R, Staniloae CS, Mavromatis K, Saw J, Hu B, Lincoff AM, Tuzcu EM. Comparison of pioglitazone vs glimepiride on progression of coronary atherosclerosis in patients with type 2 diabetes: the PERISCOPE randomized controlled trial. JAMA 2008;299:1561-1573.
48. Meuwese MC, de Groot E, Duivenvoorden R, Trip M, Ose L, Maritz FJ, Basart DCG, Kastelein JJP, Habib R, Davidson MH, Zwinderman AH, Schwocho LR, Stein EA, for the CAPTIVATE Investigators. ACAT inhibition and progression of carotid atherosclerosis in patients with familial hypercholesterole-mia: the CAPTIVATE randomized trial. JAMA 2009;301:1131-1139.
49. LaRosa JC, Grundy SM, Waters DD, Shear C, Barter P, Fruchart J-C, Gotto AM, Greten H, Kastelein JJP, Shepherd J, Wenger NK, for Treating to New Targets (TNT) Investigators. Intensive lipid lowering with atorvastatin in patients with stable coronary disease. N Engl J Med 2005;352:1425-1435.
50. Ridker PM, Morrow DA, Rose LM, Rifai N, Cannon CP, Braunwald E. Relative efficacy of atorvastatin 80 mg and pravastatin 40 mg in achieving the dual goals of low-density lipoprotein cholesterol,70 mg/dl and C-reactive protein,2 mg/l: an analysis of the PROVE-IT TIMI-22 trial. J Am Coll Cardiol 2005;17:1644-1648.
51. Barter PJ, Caufield M, Eriksson M, Grundy SM, Kastelein JJ, Komajda M, Lopez-Sendon J, Mosca L, Tardif JC, Waters JC, Shear CL, Revkin JH, Buhr KA, Fisher MR, Tall AR, Brewer B. Effect of torcetrapib in patients at high risk for coronary events. N Engl J Med 2007;357:2109-2122.
52. Davidson MH, Dembowski E. Atherosclerosis surrogate imaging trials come of age: for better or for worse? Curr Cardiol Rep 2008;10:521-525.
53. Newman AB, Naydeck BL, Ives DG, Boudreau RM, Sutton-tyrrell K, O'Leary DH, Kuller LH. Coranary artery calcium, carotid artery wall thickness, and cardiovascular disease outcomes in adults 70 to 99 years old. Am J Cardiol 2008; 101:186-192.
54. Folsom AR, Kronmal RA, Detrano RC, O'Leary DH, Bild DE, Bluemke DA, Budoff MJ, Liu K, Shea S, Szklo M, Tracy RP, Watson KE, Burke GL. Coronary artery calcification compared with carotid intima-media thickness in prediction of cardiovascular disease incidence: the Multi-Ethnic Study of Atherosclerosis (MESA). Arch Intern Med 2008;168:1333-1339.
55. Johnsen SH, Mathiesen EB. Carotid plaque compared with intima-media thickness as a predictor of coronary and cerebrovascular disease. Curr Cardiol Rep 2009;11: 21-27.
56. Spence JD. Measurement of intima-media thickness vs. carotid plaque: uses in patient care, genetic research and evaluation of new therapies. Int J Stroke 2006; 1:216-221.